Case Study in Psoriasis

Psoriasis is chronic skin problem that has been related to overacting immune system and inflammation. In psoriasis skin cells form thick red, white or silvery patches of different size appearingoften on the knees, elbows, back, hands, feet or scalp. This problem is most common in adults and in some cases runs in families. In many advanced cases psoriasis is heard to treat and treatment may continue for a lifetime.

The Study

Psoriasis is an autoimmune, chronic inflammatory skin disease characterized by thickened, red skin with silvery scaled patches. These patches typically occur on the scalp, elbows, knees, and lower back. Although the exact cause of psoriasis is not clear, it is not a contagious disease. Psoriasis affects 2-3% of the world’s population, and men and women between the ages of 15 and 45 are equally affected.

Normally, the skin cells are produced and replaced every three to four weeks. However, in psoriasis the skin cell production occurs much more rapidly than the body’s ability to shed the cells. Psoriasis is an autoimmune condition, wherein the body’s white blood cells (T lymphocytes) attack the skin cells and trigger an inflammatory response. The lymphocytes release cytokines, specifically tumor necrosis factor-alpha (TNF-alpha), which promote inflammation and accelerate the growth of the skin cells resulting in formation of “psoriatic plaques” which are scaly white and itchy skin patches at the site of inflammation.

Psoriasis is a chronic condition with periods of mild to severe symptoms. Certain factors can increase the onset of psoriasis. Stress, hormonal changes, smoking, alcohol consumption, being overweight, recurring throat or skin infections treated with strong antibiotics, medications used to treat high blood pressure, anti-malarial drugs, and over-the-counter painkiller drugs can increase the risk of a psoriasis episode.

In addition to the tremendous social and psychological impact, heart disease, diabetes and cancer are few of the complications of long standing psoriasis. In about 20% of the patients with psoriasis a complication - psoriatic arthritis - is sometimes diagnosed even before diagnosing psoriasis. A deficiency of folic acid (an essential nutrient for optimum nerve function) is common in patients with psoriasis. Currently, psoriasis does not have a satisfactory cure available and a patient requires lifelong management of the symptoms with multiple medications (which also have added side effects).

Our institute recently published a very impressive case report of a 36-year-old woman who had suffered from severe psoriasis since she was 221. The disease was present everywhere but on the face and the patient had been using topical creams for 14 years with no significant improvement. While continuing her usual treatment, the patient improved her dietary habits, and started taking a specific micronutrient combination that included vitamin C, lysine, proline, and other essential daily micronutrients in synergistic proportions. Increased intake of the micronutrients helped to reduce oxidative stress and inflammation, and improved the body’s immune response. In the second month of taking the micronutrients, the patient started noticing the psoriatic patches on the upper half of her body were healing. Improvement continued and although the leg lesions were the last to heal, at the end of six months the patient reported complete healing of all the psoriatic plaques.

While there is no satisfactory cure available as a treatment for psoriasis, such dramatic results with safe and effective micronutrients may be a ray of hope for thousands of psoriasis sufferers.

Ref. Wong, A.P., Kalinovsky, T., Niedzwiecki, A., & Rath, M. (2015). Experimental and Therapeutic Medicine, 10, 1071-1073.

Clinical Studies in Tinnitus

Tinnitus is a disease in which the subject hears ringing, whistling, knocking or similar sounds in the ears. The intensity of these sounds varies from light to unbearable. Quite often it leads to a significant hearing loss. Over 100 million people worldwide suffer from this hearing problem.

The origins of this disease are largely unknown to traditional medicine and, therefore, no therapy for its underlying causes exists. This “incurable” ringing in the ears may last for years or sometimes decades, and can lead to social isolation. Some patients find these sounds so unbearable that they are driven to suicide.

Aim of the StudyAim of the Study

This pilot study has been designed to scientifically document the effects of vitamin treatment therapy in patients suffering from tinnitus. This study was conducted in collaboration with Ear, Nose & Throat specialists. ...hide content

Study DesignStudy Design

A total of 18 patients, ranging in age from 44-85 years old and suffering from chronic tinnitus (ear ringing for more than three consecutive months), took part in the study. The patients took a daily dosage of specific vitamins for four months. They continued to take the medications prescribed by their physicians.

The patients’ hearing was measured at regular monthly intervals using a standard medical sound audiometer. The hearing improvement achieved after four months of following vitamin intake is documented below. ...hide content

Study ResultsStudy Results

After only four months of taking vitamins and other micronutrients, patients experienced the following hearing improvements:

1) In 30% of patients, hearing improved slightly (up to 10 dB).

2) In 45% of patients, hearing improved clearly ( up to10-20 dB).

3) In 25% of patients, hearing improved strongly (up to 20-50dB), which is near normal hearing ability.

More than three-fourths of the patients experienced at least some reduction in ear ringing. For more than 50% of them, ear ringing was significantly reduced or completely eliminated. ...hide content

Clinical Studies in Periodontosis

 

The term periodontosis describes an infectious form of disease in the tooth socket. As with any other infection, diagnosis is determined by symptoms that include swelling, reddening and bleeding gums, and retraction of gums with a significant loss of soft tissue or bone tissue in the tooth socket.

In the 20th century, periodontosis, like cavities, has become a virtually epidemic disease in dentistry.

Aim of the StudyAim of the Study

This pilot study has been designed to scientifically document the effects of a specific vitamin treatment in patients with symptoms of periodontosis. ...hide content

Study DesignStudy Design

Nine patients with typical symptoms of chronic periodontosis took part in the study. All of them were aware of the importance of optimal oral hygiene. The patients took a daily dosage of vitamins and other nutrients for three months. The most important component of these nutrients was vitamin C. As a diagnostic measurement of the progression of periodontosis, the “Bleeding-on-Probing” method (BoP), which is widely used in the assessment of this disease, was utilized. ...hide content

Study ResultsStudy Results

All study participants displayed similar outcomes with the vitamin treatment. The first significant changes were measurable four to six weeks after the beginning of the study.

Before the vitamin therapy, the average BoP value was 60%, which corresponds to a very advanced gum infection. From the sixth week, a clear reduction of gum bleeding was evident and by the eighth week, the average BoP had fallen to 14%. After twelve weeks (the end of the three-month pilot study), the average decrease of gum bleeding was estimated at 85%.

In addition, a significant improvement in gum firmness was noted, as was a reduction in visible vascularization, which indicated s a significant reduction of the previously spongy gum tissue fragments of beet-red color. Additional beneficial health effects were spontaneously reported by many patients, including improvement in overall physical condition and vitality. ...hide content

Clinical Studies in High Blood Pressure

 

Several hundred million people worldwide suffer from high blood pressure, the most common of all cardiovascular conditions. In more than 90 percent of the cases, the diagnosis by conventional medicine is “essential hypertension,” that is, hypertension due to unknown causes. Conventional medicine is, therefore, largely confined to treating the symptoms of hypertension without correcting the primary underlying cause, which is a “spasm” of the blood vessel wall triggered by deficiency of specific bioenergy nutrients in millions of blood vessel wall cells.

Aim of the StudyAim of the Study

Numerous reports from patients following the cellular nutrient program have shown that this program can be effective in alleviating high blood pressure conditions. This pilot study was undertaken to confirm these reports. ...hide content

Study DesignStudy Design

Fifteen subjects diagnosed with high blood pressure, ranging in age between 32-69, took part in the study over a period of four months. The patients took a daily dosage of cellular nutrients, and they also continued to take the medication prescribed by their doctors.

The patients’ blood pressure was measured at bi-weekly intervals for the four-month period of the study to ensure complete documentation of the results. Blood pressure was measured both on the right and the left upper arm. The value of these measurements in each case was used for the evaluation of the efficacy of the vitamin treatment. ...hide content

Study ResultsStudy Results

At the beginning of the study, all of the patients had elevated systolic and diastolic blood pressure values. The average systolic blood pressure value at the beginning of the study was on average 167. The average diastolic blood pressure value was 97.

After 32 weeks of the study, the blood pressure of all patients improved. At the end of the study, patients had an average systolic blood pressure reading of 142 and an average diastolic blood pressure reading of 83. These readings were 15% and 16% lower, respectively, than the measurements taken at the beginning of the study. These results were achieved without any side effects.

The cellular nutrient program helped to normalize blood pressure without causing a too-low blood pressure situation. This is another advantage of nutrients over conventional medicine, where overdosing frequently leads to decreased blood circulation, dizziness, and other health problems.  ...hide content

Clinical Studies in Heart Failure

Tens of millions of people suffer from heart failure, resulting in shortness of breath, edema, and fatigue. The origins of this disease are largely unknown to traditional medicine and, therefore, no therapy for its underlying causes exists.

Aim of the StudyAim of the Study

Cellular Health™ opens up the possibility of effective prevention and treatment of heart failure through the targeted use of micronutrients, such as vitamins, minerals, and amino acids. These micronutrients help improve cellular bioenergy levels. Suboptimal bio-energy production in the heart muscle is the most common cause of impaired heart function and heart failure.

The first study results with micronutrients in patients with heart failure are documented below. ...hide content

Study DesignStudy Design

Ten patients between the ages of 41-68 years old and with heart failure took part in a pilot study conducted over a period of six months. The patients took a daily dosage of specific micronutrients. They continued to take the medications prescribed by their physicians. The degree of heart failure was documented for every patient, using standards set by the New York Heart Association (NYHA scale).

At the beginning of the study, seven out of 10 patients suffered extensive impairment of cardiovascular health (Class 3 on the NYHA scale). Three patients reported moderate limitation of their physical activity (Class 2 on the NYHA scale).

Heart failure classification according to the New York Heart Association (NYHA):
Class 1 = No problems with normal physical activity
Class 2 = Moderate limitation of physical activity
Class 3 = Extensive limitation of physical activity
Class 4 = Bedridden ...hide content

Study ResultsStudy Results

After completion of the study, the average improvements in heart insufficiency were as follows:

In 50% of patients, no more problems appeared with normal physical activity. Twenty percent of participants reported only slight limitation of physical performance. No improvement was noted in two patients who did not adhere thoroughly to the vitamin treatment; they took it irregularly or not at all. ...hide content

Clinical Studies in Heart Disease

The coronary arteries provide the primary blood supply to the heart muscle, and coronary heart disease occurs when the arteries become blocked by a buildup of, calcium, cholesterol, and other blood factors. This fatty buildup is medically referred to as atherosclerosis, and these deposits cause the arteries to narrow and stiffen. A sudden block of the blood supply to any area of the heart muscle can cause heart attack and death.

Aim of the StudyAim of the Study

The objective of this study was to determine the effect of a defined nutritional supplement program and specific nutrient synergy on the natural progression of coronary artery disease in 55 patients (50 men and 5 women) between the ages of 44-67 with coronary artery disease as documented by Ultrafast Computed Tomography. ...hide content

Study DesignStudy Design

The study focused directly on the key problem - the atherosclerotic deposit inside the walls of the coronary arteries. For this study, Ultrafast Computed Tomography (UCT) was used. UCT is a modern technique that allows the measurement of the size of coronary deposits non-invasively. The computer automatically calculates a deposit’s size by determining the Coronary Artery Scan (CAS) score. The higher the CAS score, the more calcium has accumulated, which indicates more advanced coronary heart disease. Changes in the size of the coronary artery calcifications in each patient were measured over an average period of one year without vitamin supplementation followed by one year with the vitamin program. In this way, the heart scans of the same person was compared before and after the vitamin program. This study design had the advantage of the patients serving as their own controls. ...hide content

Study ResultsStudy Results

During the course of the 12-month nutritional supplement program, the fast growth of coronary deposits was slowed during the first six months of the study and essentially stopped during the second six months. After one year of using the specific supplement program, the coronary deposits entirely disappeared, indicating on a natural healing process of the artery wall.

For the first time in medical history, the reversal of atherosclerotic deposits without bypass surgery, angioplasty, and medication was documented. The results of this remarkable discovery were published in the Journal of Applied Nutrition in 1996.  ...hide content

Clinical Studies in Diabetes

Around the world, more than 200 million people suffer from diabetes, and approximately 18.2 million Americans are affected by this disease. Diabetes is characterized by a high sugar (glucose) level in the blood, which comes as a result of insufficient insulin production in the body, impaired cellular response to it, or both. read more...

Cellular Medicine™ provides a breakthrough in understanding the cause, prevention, and adjunct management of diabetes.

The primary reason why adult onset diabetes (Type II) develops is a long-term deficiency of specific cellular micronutrients that work in synergy in millions of cells in the pancreas (the organ that produces insulin), the liver, and the blood vessels walls. This new understanding also explains the reason for most severe consequences of diabetes, which are circulatory problems. Diabetes significantly increases the chance of developing atherosclerotic deposits, which by clogging the blood vessels can increase the risk of heart attacks, feet amputation or blindness etc.

This concept was tested in a pilot clinical trial in patients with Type II diabetes. ...read less

Aim of the StudyAim of the Study

To test the effectiveness of the specific combination of cellular nutrients on blood sugar levels in patients suffering from Type II diabetes. ...hide content

Study DesignStudy Design

Pilot clinical study was conducted in 10 patients suffering from Type II Diabetes also called adult onset diabetes. These patients took a specific micronutrient program comprising vitamins, amino acids and minerals, such as chromium, for 6-months. Blood tests were conducted to measure the effect of this nutrient synergy on blood glucose levels as well as HbA1-c levels (indicator of damage to red blood cells by glucose). before using this micronutrient program, after two months, after four months and after six months of its use. ...hide content

Study ResultsStudy Results

After 6 months of following the Cellular micronutrients program there was a decrease in blood sugar level by 23 % (from an average of 155mg/dl at the beginning of the study to 120 mg/dl at the end of the study). In addition, the HbA1-c levels in the blood were lower by an average of 9.3%. ...hide content

ConclusionConclusion

This six-month pilot study, though conducted with a small group of patients, confirmed the positive effects of the synergistic combination of cellular nutrients on regulating blood sugar levels in diabetic patients without any side effects. The effectiveness of the synergistic action of nutrients in type II diabetes has been further confirmed by several testimonials based on patient medical records. ...hide content

Clinical Studies in Cholesterol

Hundreds of millions of people have elevated blood levels of cholesterol, triglycerides, LDL (low density lipoproteins), lp(a) and other lipoproteins. According to Cellular Health™, these are actually secondary risk factors for cardiovascular disease and the consequence of ongoing vascular disease, with the primary cause being instability of blood vessel walls. Conventional medicine considers genetic and dietary risks to be the main causes of elevated cholesterol blood levels. If a change of diet doesn’t help, the medical community commonly reaches for harmful cholesterol-lowering drugs and other medicines to suppress symptoms, without addressing the underlying cause of fat metabolism problems, which is blood vessel weakness.

Aim of the StudyAim of the Study

Cellular Health™ opens up the possibility of the effective prevention and control of lipid metabolism disorders through the targeted use of nutrients synergy, such as specific vitamins, minerals, and amino acids. These micronutrients help strengthen the artery walls, thus reducing the need for elevated production in the liver of triglycerides, cholesterol, lipoprotein(a), and other risk factors that are used as “repair” factors for weak arterial walls. Thus, the primary measure for lowering cholesterol and other secondary risk factors in the bloodstream is to stabilize the artery walls, thereby decreasing the metabolic demand for the excess production of these risk factors in the liver. The nutrient synergy program tested in the study had a unique dual action. This program not only controlled the blood cholesterol and other lipid levels, but it also nourished and improved the condition of the blood vessel walls.

Following are the interim results of two clinical pilot studies in patients with elevated cholesterol and lipoprotein(a) plasma levels who have been following a nutrient synergy program for three months. ...hide content

Study DesignStudy Design

Fourteen patients, between the ages of 34-68 and suffering from fat metabolism disorders, were the participants in this study. They took daily dosages of specific cellular nutrients for three months. At the same time, they continued to take their usual prescription medications. To obtain interim results, blood tests were obtained at the beginning of the study and following twelve weeks of vitamin treatment. ...hide content

Interim Study ResultsInterim Study Results

At the beginning of the study, the average blood lipoprotein(a) level of patients was 71 mg/dl (Figure 1), and the average total cholesterol level was 293 mg/dl (Figure 2). After three months on the vitamin program, the average level of lp(a) decreased by 13%. Total cholesterol in all patients decreased by 14%, LDL decreased by 10%, triglycerides decreased by 22% and homocysteine decreased by 3%. HDL (good cholesterol) increased in this time period by 8%. It is important to note the decrease of lp(a) levels since there is no successful conventional treatment available to lower this significant blood risk factor for heart disease. Lipoprotein(a) is a tenfold greater risk factor for heart disease than cholesterol or LDL cholesterol.

Currently, we are evaluating the six-month pilot study results in patients with elevated blood cholesterol and other lipid levels. However, patients have immediately taken advantage of Dr. Rath’s discovery and his nutrient synergy program, and we received numerous testimonials that are supported by medical data. ...hide content

Clinical Studies in Atherosclerosis

The coronary arteries provide the primary blood supply to the heart muscle, and coronary heart disease occurs when the arteries become blocked by a buildup of, calcium, cholesterol, and other blood factors. This fatty buildup is medically referred to as atherosclerosis, and these deposits cause the arteries to narrow and stiffen. A sudden block of the blood supply to any area of the heart muscle can cause heart attack and death.

Aim of the StudyAim of the Study

The objective of this study was to determine the effect of a defined nutritional supplement program and specific nutrient synergy on the natural progression of coronary artery disease in 55 patients (50 men and 5 women) between the ages of 44-67 with coronary artery disease as documented by Ultrafast Computed Tomography. ...hide content

Study DesignStudy Design

The study focused directly on the key problem - the atherosclerotic deposit inside the walls of the coronary arteries. For this study, Ultrafast Computed Tomography (UCT) was used. UCT is a modern technique that allows the measurement of the size of coronary deposits non-invasively. The computer automatically calculates a deposit’s size by determining the Coronary Artery Scan (CAS) score. The higher the CAS score, the more calcium has accumulated, which indicates more advanced coronary heart disease. Changes in the size of the coronary artery calcifications in each patient were measured over an average period of one year without vitamin supplementation followed by one year with the vitamin program. In this way, the heart scans of the same person was compared before and after the vitamin program. This study design had the advantage of the patients serving as their own controls. ...hide content

Study ResultsStudy Results

During the course of the 12-month nutritional supplement program, the fast growth of coronary deposits was slowed during the first six months of the study and essentially stopped during the second six months. After one year of using the specific supplement program, the coronary deposits entirely disappeared, indicating on a natural healing process of the artery wall.

For the first time in medical history, the reversal of atherosclerotic deposits without bypass surgery, angioplasty, and medication was documented. The results of this remarkable discovery were published in the Journal of Applied Nutrition in 1996.

...hide content

 

 

Clinical Studies in Asthma

Asthma is a disorder characterized by narrowing of the lung passageways, making breathing difficult. Symptoms include recurrent attacks of shortness of breath, coughing, and wheezing. Hundreds of millions of people worldwide suffer from this illness. We are aware of many of the factors that cause asthma, but conventional medicine offers therapy only for the symptoms.

Aim of the StudyAim of the Study

Cellular Health™ opens up the possibility of effective prevention and treatment of asthma through the targeted use of micronutrients such as vitamins, minerals, and amino acids. This ongoing study tests the effects of specific vitamins on lung function in patients diagnosed with asthma. Below are the results of cellular nutrients after three months of treatment. ...hide content

Study DesignStudy Design

Eight asthma patients, between the ages of 45-75 years, are participating in the ongoing study. The subjects are taking a daily dosage of a specific nutrient combination for the six-month study period. They also continue to take their usual prescription medicines.

All asthma patients underwent pulmonary function tests at the beginning of the study and after three months (mid-point). Subsequent tests will be performed after six months of taking the specific nutrient combinations. Lung volume was measured by testing the maximal volume of exhalation after a maximal inhalation. ...hide content

Study ResultsStudy Results

After only three months on vitamin therapy, all (100%) the patients demonstrated increased lung capacity (see diagram). This means that during this relatively short period, all patients experienced an improvement in their breathing.

As soon as this pilot study is completed and we have results from the full six months of treatment, we will provide complete documentation.  ...hide content

Clinical Studies in Arthritis

Arthritis and arthrosis are very common connective tissue diseases. In arthritis, the problem is an inflammation of the bones, joints, and tendons. Chronic arthritis can lead to arthrosis, a degradation of cartilage in the joints. The cartilage can lose its elasticity, become rough and lose mass. This can result in the deformation of the cartilage. Both arthritis and arthrosis are very painful diseases, with all the typical symptoms of inflammation, including fever, reddening, and swelling. Joints may also become stiff.

Aim of the StudyAim of the Study

Cellular Health™ opens up the possibility of effective prevention and treatment of arthritis and arthrosis through the targeted use of micronutrients, such as vitamins, minerals, and amino acids. This study tested the effects of defined micronutrients on various inflammation parameters in patients diagnosed with arthritis and arthrosis. ...hide content

Study DesignStudy Design

The pilot study involved 10 patients between the ages of 45-84 years old, diagnosed with arthritis and/or arthrosis. These patients took specific vitamins daily during the six months of the study. No other medications were used. Patients in the study also underwent physical therapy treatments. As a control parameter, blood tests were performed every six weeks for various parameters that are indicators of inflammation.

The symptoms of inflammation were diagnosed in patients’ blood by analysis of erythrocyte (red blood cells) sedimentation (BSG), presence of a specific class of proteins called C-reactive proteins (CRP), and measurements of the number of leukocytes (white blood cells). In addition, x-ray pictures of the diseased areas were taken at the beginning and at the end of the study period. ...hide content

Study ResultsStudy Results

After six months of the study, the following changes in inflammation parameters in the blood were detected:

1. Blood sedimentation values (BSG) decreased in women by 35% and in men by 27%, compared to the initial values at the beginning of the study. (Figure 1)

2. Blood leukocyte levels were not affected and stayed at normal ranges for women and men at both the beginning and at the end of the study.

3. Levels of CRP at the beginning of the study were two to four times higher than normal levels in six of the 10 study participants. By the end of the study, CRP levels had dropped by an average of 30%. Both the lowering in sedimentation of the blood and the falling of CRP levels demonstrated an improvement in the incidence of inflammation among arthritic and arthrotic patients. (Figure 2)

4. X-ray examinations of diseased areas indicated an improvement in 50% patients.

This six-month pilot study, though conducted with a small group of patients, confirmed the positive effects of this vitamin program. The further effectiveness of the synergistic action of nutrients in arthritis has been confirmed by several testimonials that are based on patient medical records. ...hide content

Clinical Studies in Arrhythmia

Millions of people between the ages of 50-70 suffer from palpitations, rapid heartbeat, dizziness and shortness of breath, a condition known as arrhythmia (irregular heartbeat). Approximately 30-60 percent of men and women in this age group suffer from some form of arrhythmia at some point in their lives. In most cases, conventional medicine cannot explain why arrhythmia develops. To cover this fact, the diagnostic term “paroxysmal arrhythmia” was introduced, which simply means the causes of irregular heartbeat are unknown.

Aim of the StudyAim of the Study

The objective of our Phase II randomized, double-blind placebo-controlled clinical study was to investigate the effects of the long-term administration of a specific nutrient synergy program in combination with conventional basic therapy on the reduction of clinically apparent arrhythmic episodes in participants. The electrical cells of the heart have extraordinary nutritional demands, and a chronic deficiency of specific vitamins and other essential nutrients impairs cellular bioenergy production in heart muscle cells. This can cause disturbances in the generation and conduction of electrical impulses in the myocardium, leading to an irregular heartbeat. ...hide content

Study DesignStudy Design

randomized, double-blind placebo-controlled multi-center study (35 clinics in Germany) was conducted over 24 weeks in 131 patients with paroxysmal atrial arrhythmia. All patients were advised to continue taking their prescribed conventional medications. The nutritional supplement program consisted of specific essential bioenergy nutrients that work in synergistic way. ...hide content

Study ResultsStudy Results

There was a statistically significant effect of the vitamins on the reduction of clinically apparent arrhythmic episodes in contrast to the placebo group (p=0.0160). The mean number of episodes per patient during the six-month study was lower in the vitamin group than in the placebo group (25.1% vs. 42.4%, p=0.037). Only 47.8% of the supplemented patients reported seven or more arrhythmic episodes during the treatment study, in contrast to 73.9% reported in the placebo group. The number of patients with less then seven episodes in the supplemented group (52.7%) was almost twice that in the placebo group (26.1%). Furthermore, the number of patients with more than 10 episodes was significantly less in the supplemented group (45.5%) than in the placebo group (69.6%). The elapse of time prior to the first arrhythmic episode was shorter in the placebo group than in the supplemented group. (Log Rank Test: p = 0.0332 for PP analysis set)

With a longer period (six months) of vitamin intake, the number of patients without arrhythmia increased and the episode frequency decreased. At three months, 45.5% of the supplemented patients experienced seven or more arrhythmia attacks, in contrast to 27.3% at six months. Approximately 22.7% of the supplemented patients reported no arrhythmic episodes at three months, in contrast to 43.2% at six months.

A longer time to the first episode was observed in the supplemented group (p=0.0332). In addition, post-study quality of life improvement was greater in the supplemented group (p=0.0118). The supplemented group also demonstrated a significantly stronger perceived quality of life than did those in the placebo group (two-sided Wilcoxon rank sum: p=0.0118). An evaluation of the “mental health” measure results, for example, showed an improvement of 7.4 in the supplemented group and a decrease of –1.6 in the placebo group.

...hide content

ConclusionConclusion

By addressing the underlying cause of arrhythmia – a deficiency of nutrients that generate bioenergy in the heart muscle cells – the specific nutrients synergy program provides a safe and statistically effective reduction of arrhythmic episodes, as well as significant enhancement in general health and quality of life.

This vitamin program can be implemented in clinical practice as a safe and effective therapy in patients suffering from arrhythmia. ...hide content